An FGFR-p53 developmental signaling axis drives salivary cancer progression.
Saved in:
| Title: | An FGFR-p53 developmental signaling axis drives salivary cancer progression. |
|---|---|
| Authors: | Musicant AM; Graduate Curriculum in Genetics and Molecular Biology, Biological and Biomedical Sciences Program, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Billington JMR; Cancer Biology PhD Program, University of South Florida, Tampa, FL, USA.; Department of Tumor Microenvironment and Metastasis, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA., Damrauer JS; Department of Medicine, Division of Oncology, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Modliszewski JL; Bioinformatics Core, Lineberger Comprehensive Cancer Center, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Landau LJB; Department of Biological Sciences, University at Buffalo, Buffalo, NY, USA., Tsai YH; Bioinformatics Core, Lineberger Comprehensive Cancer Center, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Mehta JH; Department of Tumor Microenvironment and Metastasis, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA., Powers J; Department of Tumor Microenvironment and Metastasis, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA., Betancourt R; Department of Pathology and Laboratory Medicine, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Sekhri R; Center for Cancer Research, University of Tennessee Health Sciences Center, Memphis, TN, USA., Padilla RJ; Division of Diagnostic Sciences, Adams School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Hernandez-Prera JC; Department of Pathology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA., Hayes DN; Center for Cancer Research, University of Tennessee Health Sciences Center, Memphis, TN, USA., Hackman TG; Department of Otolaryngology/Head and Neck Surgery, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Gokcumen O; Department of Biological Sciences, University at Buffalo, Buffalo, NY, USA., Knox SM; Department of Cell and Tissue Biology, University of California San Francisco, San Francisco, CA, USA.; Program in Craniofacial Biology, University of California San Francisco, San Francisco, CA, USA., Amelio AL; Department of Tumor Microenvironment and Metastasis, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA. antonio.amelio@moffitt.org.; Department of Head and Neck-Endocrine Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA. antonio.amelio@moffitt.org. |
| Source: | Oncogene [Oncogene] 2025 Aug; Vol. 44 (32), pp. 2876-2892. Date of Electronic Publication: 2025 Jun 02. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5594 (Electronic) Linking ISSN: 09509232 NLM ISO Abbreviation: Oncogene Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
